Merger of East Sussex Community Health Services with South Downs Health NHS trust

The provider services arm for East Sussex Downs and Weald PCT and Hastings and Rother PCT (East Sussex Community Health Services) is proposing to merge with South Downs Health NHS Trust.

Consistent with its draft interim merger guidelines, the CCP will examine the costs and benefits of the proposed merger to patients and taxpayers, in order to ascertain whether the transaction is consistent with Principles 9 and 10 of the Principles and Rules for Cooperation and Competition.* In doing so, the CCP will consider the effect of the transaction on patient choice and competition for community health services in: East Sussex, Downs and Weld and / or Hastings and Rother, or a wider area.

The CCP welcomes submissions in writing from interested individuals and organisations on this issue or any other matter relevant to the CCP's assessment of this transaction under the Principles and Rules for Cooperation and Competition. To submit evidence please use the email address: cases@ccpanel.gsi.gov.uk.

The closing date for submissions is 8 October 2010.

* From 1 October 2010 the revised Principles and Rules for Cooperation and Competition will apply. However, we will consider this application for CCP review under the version of the Principles and Rules valid on the date of the Notice of Acceptance for this case.

Case documents

Notice of Acceptance (22/09/10) [192 KB]

Administrative timetable

Event Date
CCP publishes Notice of Acceptance 22 September 2010
Closing date for Phase 1 submissions 8 October 2010
Deadline for completion of Phase 1 ** 17 November 2010
Deadline for completion of Phase 2 (if required)*** 14 March 2011

** At the end of Phase 1, the CCP will either:

  • recommend that the merger be allowed to proceed, or
  • recommend that the merger be allowed to proceed subject to measures agreed with the parties that address concerns identified by the CCP during Phase 1, or
  • proceed to a more detailed Phase 2 investigation.

*** Phase 2 allows the CCP to conduct a more in-depth investigation where this is required to fully assess a merger.

NB. This timetable will be updated as required during the course of the inquiry.


Department of Health NHS Monitor